GlobeNewsWire
06 Mar 2026, 13:00 UTC · 28w ago
Verdict
Headline takes no side. We score VTAK +0.60 across three claims — strongly bullish.
+0.60strongly bullish
More positive than 74% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Catheter Precision's LockeT device will be featured in live procedural cases at the International Symposium of Left Atrial Appendage 2026.
More positive than 64% of claims this week
The LockeT suture retention device is an FDA Class 1 registered device with CE Mark approval.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 51% of claims this week
The LockeT device claims to provide benefits including hospital cost reduction and same-day hospital discharge.
More positive than 51% of claims this week
Which stocks this story touches
More positive than 74% of ticker scores this week
The company is showcasing its LockeT device at a prestigious industry conference, highlighting product benefits and gaining professional traction.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
2h ago
−89.0%
Price is moving against the score
$0.1586 vs $1.44 close before publication (Mar 5) · not market-adjusted
VTAK chart →
